|
|
||||||||
1 Division of Clinical
Pharmacology and Toxicology, The rat liver organic anion transporting
polypeptide (Oatp1) has been extensively characterized mainly in the
Xenopus laevis expression system as a
polyspecific carrier transporting organic anions (bile salts), neutral
compounds, and even organic cations. In this study, we extended this
characterization using a mammalian expression system and confirm the
basolateral hepatic expression of Oatp1 with a new antibody. Besides
sulfobromophthalein [Michaelis-Menten constant
(Km) of ~3
µM], taurocholate
(Km of ~32
µM), and estradiol- 17
sodium-independent organic anion transport; multispecificity; Chinese hamster ovary cells
DETOXIFICATION OF endo- and xenobiotics is a major
function of the liver. Hepatic uptake of many of these amphipathic
compounds is mediated by polyspecific organic anion transporting
polypeptides (Oatp) that have been cloned from liver, brain, and kidney
(20). The first member of the Oatp
gene family of membrane transporters (Oatp1) has been isolated from rat
liver and shown to mediate Na+-independent saturable
transport of sulfobromophthalein (BSP) [Michaelis-Menten constant
(Km) of
1.5-3.3 µM] and taurocholate (Km of 19-50
µM) when expressed in Xenopus laevis
oocytes (11, 16) and in transfected HeLa cells (12, 30, 32). Oatp1 represents an ~80-kDa glycoprotein that in addition to the
basolateral plasma membrane of hepatocytes is also localized at the
apical membranes of kidney proximal tubule (S3 segment) (3) and choroid plexus epithelial cells (2). The endogenous substrates as well as the
transport mechanism are not definitively elucidated yet. In stably
transfected HeLa cells, Oatp1 has been shown to function as a
taurocholate/HCO Materials
[3H]DHEAS (16 Ci/mmol),
[3H]taurocholic acid
(2.6 Ci/mmol),
[3H]cholic acid (13.2 Ci/mmol),
[3H]estrone-3-sulfate
(49.0 Ci/mmol),
[3H]estradiol-17 Antibody production, immunofluorescence, and Western blotting.
The cDNA coding for the last 40 amino acids of Oatp1 (11) was PCR
amplified using the following primers:
5'-GACATTGACTCTTCAGCAACTG-3' (corresponding to nucleotides
1977-1998) and 5'-CTGTTCATGGCCTTGAACAGG-3' (corresponding to nucleotides 2135-2115). The blunted PCR product was cloned into the Asp700-cut pMAL-c2. After
sequencing was performed to verify the correct in-frame subcloning, the
fusion protein between Oatp1 and the maltose binding protein of
E. coli was isolated and a rabbit was
immunized as described (34). The antibody raised did not cross-react
with Oatp2 (21) as verified in separate in vitro expression and in vivo
localization experiments (data not shown). Immunofluorescence was
performed as described previously (34). SDS-PAGE and Western blotting
were performed according to standard procedures (17, 26).
Stable transfection of Chinese hamster ovary cells with Oatp1.
The complete coding region of Oatp1 was cut out from the original
plasmid (11) using Sal I and
Hind III. This region was blunt ended
and then subcloned into the Stu
I-digested and dephosphorylated pCMV vector-1 (31). This construct was
introduced into CHO cells by electroporation, and stably transfected
cells were selected by adding G418 to the culture medium. From the
resulting transfected cell pool, single clones were isolated with the
use of cloning cylinders and tested for
Na+-independent taurocholate
uptake. Clone CHO-03 exhibited the highest transport activity of
taurocholate and was selected for use in all further experiments.
Cell culture.
CHO cells were grown in DMEM supplemented with 10% FCS, 2 mM
L-glutamine, 50 µg/ml
L-proline, 100 U/ml penicillin,
100 µg/ml streptomycin, and 0.5 µg/ml Fungizone (amphotericin B) at
37°C with 5% CO2 and 95%
humidity. Selective medium contained additional 400 µg/ml G418
sulfate (Geneticin).
Uptake studies in CHO cells.
Determination of Na+-independent
uptake of potential substrates for Oatp1 was performed as described
(31). For some experiments, expression of Oatp1 was induced by
incubation of the cells for 24 h with culture medium supplemented with
5 mM butyrate as described (22). For determination of the kinetic
parameters, the linear range of uptake was first determined for each
substrate individually. Transport was then measured at a time point
well within this linear range (usually 20-30 s), and net uptake
values used for the calculation of the kinetic parameters were obtained
by subtracting the uptake values obtained with wild-type CHO-K1 cells
from values obtained with stably transfected CHO-03 cells. Because
preliminary experiments did not demonstrate any
Na+ dependency, all uptake
experiments were performed in choline chloride-containing solutions.
Determination of protein concentration.
Protein concentrations were determined using the bicinchoninic acid
protein assay kit (Pierce, Rockford, IL) (33).
The antiserum generated against the fusion protein of the COOH-terminal
40 amino acids of Oatp1 and the maltose binding protein of
E. coli was tested by Western blot
analysis with rat liver basolateral and canalicular membrane vesicles.
As shown in Fig. 1 (lane
1), the antiserum reacted with an antigen in the
basolateral membrane fraction, yielding a single broad band with an
apparent molecular mass of 81 ± 6 kDa (mean ± SD of 6 independent determinations). The signal was virtually absent in the
canalicular lane (Fig. 1, lane 2),
confirming the selective localization of Oatp1 to the basolateral
plasma membrane domain of hepatocytes (3). The specificity of the
signal was tested by preincubation of the antiserum with the fusion
protein (Fig. 1, lanes 3 and
4). The results demonstrate that the
raised antiserum is specific for a single 81-kDa basolateral liver
plasma membrane protein.
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-glucuronide
(Km of ~4
µM), substrates previously shown to be transported by Oatp1 in
transfected HeLa cells, we determined the kinetic parameters for
cholate (Km of
~54 µM), glycocholate (Km of ~54
µM), estrone-3-sulfate
(Km of ~11
µM), CRC-220
(Km of ~57
µM), ouabain
(Km of ~3,000
µM), and ochratoxin A
(Km of ~29
µM) in stably transfected Chinese hamster ovary (CHO) cells. In
addition, three new substrates, taurochenodeoxycholate
(Km of ~7
µM), tauroursodeoxycholate
(Km of ~13
µM), and dehydroepiandrosterone sulfate
(Km of ~5
µM), were also investigated. The results establish the polyspecific
nature of Oatp1 in a mammalian expression system and definitely
identify conjugated dihydroxy bile salts and steroid conjugates as
high-affinity endogenous substrates of Oatp1.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
3 exchanger (30),
whereas in Xenopus laevis oocytes
Oatp1-mediated taurocholate transport was transstimulated by reduced
glutathione (19). Besides BSP and taurocholate, Oatp1 has been shown to
transport also estradiol-17
-glucuronide in transfected HeLa cells
(13, 30, 32). In addition, with the use of the Xenopus
laevis expression system, a wide variety of
structurally unrelated compounds have been suggested to be transported
by Oatp1, including the steroid conjugates estrone-3-sulfate (Km of ~4.5
µM) (5), the neutral steroids aldosterone
(Km of ~15 nM),
cortisol (Km of
~13 nM), and ouabain
(Km of 1,700 µM) (5), the thrombin inhibitor CRC-220
(Km of ~30
µM) (7), and the mycotoxin ochratoxin A
(Km of ~ 17 µM) (14). So far, the kinetic parameters of only three substrates
have been determined in a mammalian expression system (13, 30, 32).
Furthermore, the kinetics of Oatp1-mediated uptake of bile salts has
only been determined for taurocholate (16). This gap of knowledge is
closed in this study with the use of stably transfected Chinese hamster ovary (CHO) cells to determine the kinetic parameters of several bile
salts and various nonbile acid endo- and xenobiotics in a mammalian
expression system. The results demonstrate that similar to the
Na+-taurocholate cotransporting
polypeptide (Ntcp) (31), Oatp1 also exhibits the highest affinity for
the dihydroxy bile salt taurochenodeoxycholate among all bile salts
tested. Furthermore, the steroid conjugates, including the newly
characterized dehydroepiandrosterone sulfate (DHEAS), have been
identified as substrates with the highest affinities for Oatp1,
supporting the concept that these conjugates represent important
endogenous substrates of Oatp1.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-D-glucuronide
(49 Ci/mmol), and
[3H]ouabain (20.5 Ci/mmol) were obtained from DuPont NEN (Boston, MA).
[35S]BSP (4.1 Ci/mmol)
was kindly provided by A. W. Wolkoff of Albert Einstein College of
Medicine (Bronx, NY), CRC-220 by W. Stüber of Behringwerke
(Marburg, Germany),
[3H]ochratoxin A by E. Petzinger of Justus Liebig-Universität (Giessen, Germany), and
[2-3H]taurochenodeoxycholate
(0.5 Ci/mmol) and
[2-3H]tauroursodeoxycholate
(0.5 Ci/mmol) by A. W. Hofmann and C. D. Schteingart of University of
California at San Diego (La Jolla, CA). All cell culture media and
reagents were obtained from Life Technologies (Paisley, UK). All other
chemicals and reagents were of analytical grade and were readily
available from commercial sources.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (62K):
[in a new window]
Fig. 1.
Characterization of antiserum raised against organic anion transporting
polypeptide (Oatp1) in rat liver basolateral and canalicular membrane
vesicles. Seventy-five micrograms of rat liver basolateral
(lanes 1 and
3) or canalicular
(lanes 2 and
4) membrane vesicles were separated
using 7.5% SDS-PAGE and subsequently transferred to nitrocellulose.
Western blot was incubated with a 1:2,000 dilution of the Oatp1
antiserum (lanes 1 and
2) or with Oatp1 antiserum
preabsorbed with the fusion protein used to raise the antiserum
(lanes 3 and
4). Bound antibodies were visualized
using 125I-labeled protein A. Molecular mass standards are indicated on the
right (in kDa).
To localize the native Oatp1 in intact rat liver, the antiserum was
used on cryosections for immunofluorescence studies. As demonstrated in
Fig. 2 and supporting the Western blot
results from Fig. 1, Oatp1 immunoreactivity is restricted to the
basolateral plasma membrane of hepatocytes. No immunostaining could be
detected at the canalicular domain (Fig. 2). In addition, biliary
epithelial cells were immunonegative for Oatp1 (data not shown).
|
To prove that the immunopositive basolateral hepatocyte antigen indeed
represents the native Oatp1, we next investigated whether expression of
cell surface immunopositivity is associated with Na+-independent transport of BSP.
As demonstrated in Fig. 3, CHO cells stably
transfected with Oatp1 cDNA (CHO-03) exhibited immunopositive surface
staining as well as
Na+-independent BSP uptake. In
contrast, wild-type CHO-K1 cells were immunonegative and showed only
minimal BSP uptake. These results demonstrate that the immunopositive
protein represents the functionally active rat liver Oatp1.
|
In a previous study, CHO cells stably expressing Ntcp showed a
~10-fold stimulation of
Na+-dependent uptake of bile salts
when gene expression was induced by sodium butyrate (31). As
illustrated in Fig. 4, sodium butyrate exerted a similar inducing effect on the expression of Oatp1 in stably
transfected CHO-03 but not in wild-type CHO-K1 cells. Thus sodium
butyrate increased the maximal velocity
(Vmax) value
for Oatp1-mediated estrone-3-sulfate uptake ~10-fold, whereas the Km value remained
unchanged (Table 1). Because high level
expression is important for the correct delineation of the substrate
specificity of a given transport system, we performed all subsequent
transport studies under butyrate-induced conditions. On the basis of
previous initial uptake activities (20), we next determined the
kinetics of a variety of established and new Oatp1 substrates. As
demonstrated in Table 1, BSP and estradiol-17
-glucuronide exerted
the highest affinities for Oatp1
(Km of ~3 µM)
among all substrates tested. These results are similar to previous
studies in Xenopus laevis oocytes (11,
16) and in transfected HeLa cells (13), respectively. Second were
taurocheno- and tauroursodeoxycholate, DHEAS, and estrone-3-sulfate
(Km values of
5-13 µM) (Table 1). The identification of DHEAS as a new
substrate of Oatp1 (Fig. 5) supports the
concept that endogenous steroid conjugates are important physiological high-affinity substrates of Oatp1 (13). A third group of substrates with Km values
between 29 and 57 µM included ochratoxin A, taurocholate, cholate,
glycocholate, and CRC-220 (Table 1). Finally, the studies in stably
transfected CHO-03 cells confirmed the low affinity of Oatp1 for
ouabain (Km of
~3,000 µM) (5). These studies in stably transfected CHO-03 cells
confirm the polyspecific substrate spectrum of Oatp1 and identify
dihydroxy bile salts and DHEAS as new high-affinity Oatp1 substrates.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Previous studies in Oatp1-expressing Xenopus
laevis oocytes and in transfected HeLa cells have
provided evidence that Oatp1 mediates transport of a wide variety of
amphipathic compounds (5, 11-13, 16, 20, 32). Among several
anionic, neutral, and even cationic substrates identified, only the
anions BSP, taurocholate, and estradiol-17
-glucuronide have been
characterized in a mammalian expression system (12, 13, 32). In this
study, we directly correlate surface expression of Oatp1 and
multispecific transport of several anionic as well as neutral compounds
in a stably transfected mammalian CHO cell line (Figs. 3-5).
The antibody generated against the COOH-terminal end of Oatp1 recognized an ~81-kDa antigen at the basolateral membrane of hepatocytes (Figs. 1 and 2), which is similar to previous studies using a different antibody raised against a 13-amino acid peptide close to the COOH-terminal end (3). The antigen used to generate our new antibody encompasses the last 40 amino acids of Oatp1. The specificity for Oatp1 is indicated by an amino acid identity of the epitope of 70% to Oatp3 (1), 61% to OAT-K1 (29), and only 56% to Oatp2 (21). Furthermore, the specificity of the antibody for Oatp1 is supported by the observation of 1) basolateral immunopositivity in hepatocytes (Fig. 2), which do not express Oatp3 (1), and 2) a distinct distribution of Oatp2 in liver (24) and choroid plexus (8). The positive correlation between immunostaining of the plasma membrane and transport of BSP in the CHO-03 cells (Fig. 3) definitively shows that the basolateral protein recognized by the antiserum indeed represents functionally active Oatp1.
Because high level expression of a transport protein is required for
correct delineation of its substrate specificity and kinetic transport
parameters (31), we treated the stably transfected CHO-03 cells with 5 mM sodium butyrate. Similar to Ntcp-expressing CHO 9-6 cells (31),
butyrate induction also resulted in a 10-fold increase of
Oatp1-mediated estrone-3-sulfate uptake (Fig. 4; Table 1). This
butyrate-induced expression level of Oatp1 in CHO-03 cells is about
fivefold higher than in hepatocytes, as estimated on the basis of the
apparent Vmax
values for Na+-independent cholate
uptake (Table 1; Ref. 4). A similar increase in Oatp1 expression is
also evident in comparison to stably transfected HeLa cells (30, 32).
Hence, butyrate-induced CHO-03 cells were routinely used to determine
the kinetics of a variety of presumptive Oatp1 substrates not
previously tested in a mammalian cell system. On the basis of the ratio
of Vmax to
Km, the best transport substrate of Oatp1 was BSP followed by the dihydroxylated bile salts taurourso- and taurochenodeoxycholate, the steroid conjugates estradiol-17
-glucuronide, estrone-3-sulfate, and DHEAS, the mycotoxin ochratoxin A, the trihydroxylated bile salts cholate, glycocholate, and taurocholate, and the thrombin inhibitor CRC-220 (Table 1). Similar to previous studies in Xenopus
laevis oocytes, the cardiac glycoside ouabain exhibited
by far the lowest affinity for Oatp1 among all substrates tested (Table
1). Our results indicate that dihydroxy bile salts and steroid 3 and 17 conjugates represent important endogenous substrates of Oatp1. This
conclusion is further supported by the identification of DHEAS as a new
high-affinity endogenous substrate of Oatp1 (Fig. 5; Table 1). DHEAS is
also transported by the human OATP with an apparent
Km value of ~7 µM (15). Because the concentration of DHEAS in human blood plasma reaches 10 µmol/l and because OATP is widely distributed in the human
brain, it is possible that OATP plays an important role in the
intracerebral distribution and action of DHEAS in humans (15). In the
rat, the physiological role of Oatp1 in the disposition of DHEAS and
other steroid conjugates is most probably concentrated in the liver and
kidney (3, 25), since cerebral expression of Oatp1 is confined to the
apical portion of choroid plexus epithelial cells only (2).
Besides endogenous substrates, Oatp1 also mediates transport of the mycotoxin ochratoxin A (Table 1, Ref. 14), which is a frequent contaminant of food and animal chow (14, 27). Its principal mechanism of action is inhibition of protein synthesis by competition with phenylalanine. The main target organ for ochratoxin A toxicity is the kidney, whereas the liver is less frequently affected (27), most likely because in the liver the toxin is rapidly glucuronidated, sulfated, and excreted into bile (28). In the kidney, ochratoxin A is reabsorbed in the proximal straight tubule, resulting in toxic intracellular concentrations of the mycotoxin in kidney epithelial cells (6). Interestingly, renal reabsorption of ochratoxin A can be partially inhibited by BSP (6), which represents a classical high-affinity substrate of Oatp1 (11) (Table 1). Moreover, a significant portion of peritubular uptake of ochratoxin A is probenecid sensitive and p-aminohippurate insensitive (9). These characteristics of renal ochratoxin A transport could be explained by Oatp1-mediated transport (16), since Oatp1 is also localized at the brush-border membrane of the late proximal straight tubule (S3) (3). Thus, in addition to uptake into hepatocytes, Oatp1 might play a role in the renal reabsorption of ochratoxin A and thus significantly contribute to the overall nephrotoxicity of this mycotoxin. Whether Oatp1 and/or other members of the Oatp gene family of membrane transporters are also involved in hepatic and/or renal transport of other mycotoxins such as microcystin is not yet known and remains to be investigated.
In conclusion, the present study proves the multispecific nature of Oatp1-mediated amphipathic substrate transport in a mammalian cell system. In addition to the substrates identified previously and in this study, recent evidence indicates that Oatp1 can also transport glutathione conjugates, leukotriene C4, and certain dipeptidic drugs (10, 19, 23). In one of these studies, leukotriene C4 exhibited a very high affinity for Oatp1 (Km of ~0.27 µM), indicating that Oatp1 mediates leukotriene C4 uptake into hepatocytes under physiological conditions (18, 19). Furthermore, reduced glutathione efflux has been proposed as a new driving force for Oatp1-mediated substrate uptake into hepatocytes (19). Hence, the importance of Oatp1 as a polyspecific organic anion and drug transporter is increasingly recognized. Furthermore, additional members of the Oatp gene family of membrane transporters have been cloned and shown to exhibit partially overlapping substrate specificities with Oatp1 (1, 20). Thus exact delineation of the transport characteristics of each Oatp in high expression mammalian cell systems is important in defining the physiological and pathophysiological roles of individual Oatps in the normal and diseased body.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by Swiss National Science Foundation Grants 31-45536.95 and 31-45677.95 (to P. J. Meier and B. Hagenbuch). B. Hagenbuch is a recipient of a Cloëtta Foundation Fellowship.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: B. Hagenbuch, Division of Clinical Pharmacology and Toxicology, Dept. of Medicine, Univ. Hospital, CH-8091 Zürich, Switzerland (E-mail: Bruno.Hagenbuch{at}access.unizh.ch).
Received 9 June 1998; accepted in final form 22 January 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abe, T.,
M. Kakyo,
H. Sakagami,
T. Tokui,
T. Nishio,
M. Tanemoto,
H. Nomura,
S. C. Hebert,
S. Matsuno,
H. Kondo,
and
H. Yawo.
Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2.
J. Biol. Chem.
273:
22395-22401,
1998
2.
Angeletti, R. H.,
P. M. Novikoff,
S. R. Juvvadi,
J. M. Fritschy,
P. J. Meier,
and
A. W. Wolkoff.
The choroid plexus epithelium is the site of the organic anion transport protein in the brain.
Proc. Natl. Acad. Sci. USA
94:
283-286,
1997
3.
Bergwerk, A. J.,
X. Y. Shi,
A. C. Ford,
N. Kanai,
E. Jacquemin,
R. D. Burk,
S. Bai,
P. M. Novikoff,
B. Stieger,
P. J. Meier,
V. L. Schuster,
and
A. W. Wolkoff.
Immunologic distribution of an organic anion transport protein in rat liver and kidney.
Am. J. Physiol.
271 (Gastrointest. Liver Physiol. 34):
G231-G238,
1996
4.
Boelsterli, U. A.,
B. Zimmerli,
and
P. J. Meier.
Identification and characterization of a basolateral dicarboxylate/cholate antiport system in rat hepatocytes.
Am. J. Physiol.
268 (Gastrointest. Liver Physiol. 31):
G797-G805,
1995
5.
Bossuyt, X.,
M. Müller,
B. Hagenbuch,
and
P. J. Meier.
Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
J. Pharmacol. Exp. Ther.
276:
891-896,
1996
6.
Dahlmann, A.,
W. H. Dantzler,
S. Silbernagl,
and
M. Gekle.
Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: the nephrotoxin can be reabsorbed in all nephron segments by different mechanisms.
J. Pharmacol. Exp. Ther.
286:
157-162,
1998
7.
Eckhardt, U.,
J. A. Horz,
E. Petzinger,
W. Stüber,
M. Reers,
G. Dickneite,
H. Daniel,
M. Wagener,
B. Hagenbuch,
B. Stieger,
and
P. J. Meier.
The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat-liver organic anion-transporting polypeptide.
Hepatology
24:
380-384,
1996[Medline].
8.
Gao, B., B. Stieger, and P. J. Meier. Organ and
cellular distribution of the organic anion transporting polypeptide 2 (oatp2) in rat (Abstract). J. Hepatol.
28, Suppl.: 124, 1998.
9.
Groves, C. E.,
M. Morales,
and
S. H. Wright.
Peritubular transport of ochratoxin A in rabbit renal proximal tubules.
J. Pharmacol. Exp. Ther.
284:
943-948,
1998
10.
Ishizuka, H.,
K. Konno,
H. Naganuma,
K. Nishimura,
H. Kouzuki,
H. Suzuki,
B. Stieger,
P. J. Meier,
and
Y. Sugiyama.
Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide.
J. Pharmacol. Exp. Ther.
287:
37-42,
1998
11.
Jacquemin, E.,
B. Hagenbuch,
B. Stieger,
A. W. Wolkoff,
and
P. J. Meier.
Expression cloning of a rat liver Na+-independent organic anion transporter.
Proc. Natl. Acad. Sci. USA
91:
133-137,
1994
12.
Kanai, N.,
R. Lu,
Y. Bao,
A. W. Wolkoff,
and
V. L. Schuster.
Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates.
Am. J. Physiol.
270 (Renal Fluid Electrolyte Physiol. 39):
F319-F325,
1996
13.
Kanai, N.,
R. Lu,
Y. Bao,
A. W. Wolkoff,
M. Vore,
and
V. L. Schuster.
Estradiol 17
-D-glucuronide is a high-affinity substrate for oatp organic anion transporter.
Am. J. Physiol.
270 (Renal Fluid Electrolyte Physiol. 39):
F326-F331,
1996
14.
Kontaxi, M.,
U. Eckhardt,
B. Hagenbuch,
B. Stieger,
P. J. Meier,
and
E. Petzinger.
Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide.
J. Pharmacol. Exp. Ther.
279:
1507-1513,
1996
15.
Kullak-Ublick, G. A.,
T. Fisch,
M. Oswald,
B. Hagenbuch,
P. J. Meier,
U. Beuers,
and
G. Paumgartner.
Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain.
FEBS Lett.
424:
173-176,
1998[Medline].
16.
Kullak-Ublick, G.-A.,
B. Hagenbuch,
B. Stieger,
A. W. Wolkoff,
and
P. J. Meier.
Functional characterization of the basolateral rat liver organic anion transporting polypeptide.
Hepatology
20:
411-416,
1994[Medline].
17.
Laemmli, U. K.
Cleavage of strucural proteins during the assembly of the head of bacteriophage T4.
Nature
227:
680-685,
1979.
18.
Leier, I.,
M. Müller,
G. Jedlitschky,
and
D. Keppler.
Leukotriene uptake by hepatocytes and hepatoma cells.
Eur. J. Biochem.
209:
281-289,
1992[Medline].
19.
Li, L. Q.,
T. K. Lee,
P. J. Meier,
and
N. Ballatori.
Identification of glutathione as a driving force and leukotriene C-4 as a substrate for Oatp1, the hepatic sinusoidal organic solute transporter.
J. Biol. Chem.
273:
16184-16191,
1998
20.
Meier, P. J.,
U. Eckhardt,
A. Schroeder,
B. Hagenbuch,
and
B. Stieger.
Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver.
Hepatology
26:
1667-1677,
1997[Medline].
21.
Noé, B.,
B. Hagenbuch,
B. Stieger,
and
P. J. Meier.
Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain.
Proc. Natl. Acad. Sci. USA
94:
10346-10350,
1997
22.
Palermo, D. P.,
M. E. DeGraaf,
D. R. Marotti,
E. Rehberg,
and
L. E. Post.
Production of analytical quantities of recombinant proteins in chinese hamster ovary cells using sodium butyrate to elevate gene expression.
J. Biotechnol.
19:
35-48,
1991[Medline].
23.
Pang, K. S.,
P. J. Wang,
A. Chung,
and
A. W. Wolkoff.
The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein.
Hepatology
28:
1341-1346,
1998[Medline].
24.
Reichel, C.,
B. Gao,
V. Cattori,
L. Landmann,
Y. Sugiyama,
B. Stieger,
B. Hagenbuch,
and
P. J. Meier.
Heterogeneous expression of the polyspecific organic anion transporter oatp2 in rat liver and its identification as a cyclic peptide transporter (Abstract).
Hepatology
28:
425A,
1998.
25.
Reuter, S.,
and
D. Mayer.
Transport of dehydroepiandrosterone and dehydroepiandrosterone sulphate into rat hepatocytes.
J. Steroid Biochem. Mol. Biol.
54:
227-235,
1995[Medline].
26.
Roman, L. M.,
and
A. L. Hubbard.
A domain specific marker for the hepatocyte plasma membrane: localization of leucine aminopeptidase to the bile canalicular domain.
J. Cell Biol.
96:
1548-1558,
1983
27.
Röschenthaler, R.,
E. E. Creppy,
and
G. Dirheimer.
Ochratoxin A: on the mode of action of a ubiquitous mycotoxin.
J. Toxicol. Sci.
3:
53-86,
1984.
28.
Roth, A.,
K. Chakor,
E. E. Creppy,
A. Kane,
R. Roschenthaler,
and
G. Dirheimer.
Evidence for an enterohepatic circulation of ochratoxin A in mice.
Toxicology
48:
293-308,
1988[Medline].
29.
Saito, H.,
S. Masuda,
and
K. Inui.
Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney.
J. Biol. Chem.
271:
20719-20725,
1996
30.
Satlin, L. M.,
V. Amin,
and
A. W. Wolkoff.
Organic anion transporting polypeptide mediates organic anion/HCO
3 exchange.
J. Biol. Chem.
272:
26340-26345,
1997
31.
Schroeder, A.,
U. Eckhardt,
B. Stieger,
R. Tynes,
C. D. Schteingart,
A. F. Hofmann,
P. J. Meier,
and
B. Hagenbuch.
Substrate specificity of the rat liver Na+-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells.
Am. J. Physiol.
274 (Gastrointest. Liver Physiol. 37):
G370-G375,
1998
32.
Shi, X. Y.,
S. Bai,
A. C. Ford,
R. D. Burk,
E. Jacquemin,
B. Hagenbuch,
P. J. Meier,
and
A. W. Wolkoff.
Stable inducible expression of a functional rat liver organic anion transport protein in HeLa cells.
J. Biol. Chem.
270:
25591-25595,
1995
33.
Smith, P. K.,
R. I. Krohn,
G. T. Hermanson,
A. K. Mallia,
F. H. Gartner,
M. D. Provenzano,
E. K. Fujimoto,
N. M. Goeke,
B. J. Olson,
and
D. C. Klenk.
Measurement of protein using bicinchoninic acid.
Anal. Biochem.
150:
76-85,
1985[Medline].
34.
Stieger, B.,
B. Hagenbuch,
L. Landmann,
M. Höchli,
A. Schroeder,
and
P. J. Meier.
In situ localization of the hepatocytic Na+/taurocholate cotransporting polypeptide (Ntcp) in rat liver.
Gastroenterology
107:
1781-1787,
1994[Medline].
35.
Stieger, B.,
P. J. Meier,
and
L. Landmann.
Effect of obstructive cholestasis on membrane traffic and domain-specific expression of plasma membrane proteins in rat liver parenchymal cells.
Hepatology
20:
201-212,
1994[Medline].
This article has been cited by other articles:
![]() |
S. Leuthold, B. Hagenbuch, N. Mohebbi, C. A. Wagner, P. J. Meier, and B. Stieger Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters Am J Physiol Cell Physiol, March 1, 2009; 296(3): C570 - C582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Campion, R. Johnson, L. M. Aleksunes, M. J. Goedken, N. van Rooijen, G. L. Scheffer, N. J. Cherrington, and J. E. Manautou Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G294 - G304. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Huber, B. Gao, M.-A. Sidler Pfandler, W. Zhang-Fu, S. Leuthold, B. Hagenbuch, G. Folkers, P. J. Meier, and B. Stieger Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain Am J Physiol Cell Physiol, February 1, 2007; 292(2): C795 - C806. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sykes, D. H. Sweet, S. Lowes, S. K. Nigam, J. B. Pritchard, and D. S. Miller Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice Am J Physiol Renal Physiol, May 1, 2004; 286(5): F972 - F978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hata, P. Wang, N. Eftychiou, M. Ananthanarayanan, A. Batta, G. Salen, K. S. Pang, and A. W. Wolkoff Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G829 - G839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Houle, J. Raoul, J.-F. Levesque, K. S. Pang, D. A. Nicoll-Griffith, and J. M. Silva Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes Drug Metab. Dispos., April 1, 2003; 31(4): 447 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Leazer and C. D. Klaassen The Presence of Xenobiotic Transporters in Rat Placenta Drug Metab. Dispos., February 1, 2003; 31(2): 153 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Mendoza, M. J. Monte, M. A. Serrano, M. Pastor-Anglada, B. Stieger, P. J. Meier, M. Medarde, and J. J. G. Marin Physiological characteristics of allo-cholic acid J. Lipid Res., January 1, 2003; 44(1): 84 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, B. Stieger, P. J. Meier, and M. Vore Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G757 - G766. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kato, K. Kuge, H. Kusuhara, P. J. Meier, and Y. Sugiyama Gender Difference in the Urinary Excretion of Organic Anions in Rats J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 483 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gotoh, Y. Kato, B. Stieger, P. J. Meier, and Y. Sugiyama Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta -D-glucuronide in rats Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1245 - E1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawabata, S. Furuta, Y. Shinozaki, T. Kurimoto, and R. Nishigaki Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver Drug Metab. Dispos., May 1, 2002; 30(5): 498 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li, D. P. Hartley, N. J. Cherrington, and C. D. Klaassen Tissue Expression, Ontogeny, and Inducibility of Rat Organic Anion Transporting Polypeptide 4 J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 551 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagata, H. Kusuhara, H. Endou, and Y. Sugiyama Expression and Functional Characterization of Rat Organic Anion Transporter 3 (rOat3) in the Choroid Plexus Mol. Pharmacol., May 1, 2002; 61(5): 982 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Briz, M. A. Serrano, N. Rebollo, B. Hagenbuch, P. J. Meier, H. Koepsell, and J. J.G. Marin Carriers Involved in Targeting the Cytostatic Bile Acid-Cisplatin Derivatives cis-Diammine-chloro-cholylglycinate-platinum(II) and cis-Diammine-bisursodeoxycholate-platinum(II) toward Liver Cells Mol. Pharmacol., April 1, 2002; 61(4): 853 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Guo, D. R. Johnson, and C. D. Klaassen Postnatal Expression and Induction by Pregnenolone-16alpha -Carbonitrile of the Organic Anion-Transporting Polypeptide 2 in Rat Liver Drug Metab. Dispos., March 1, 2002; 30(3): 283 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Guo, S. Choudhuri, and C. D. Klaassen Induction Profile of Rat Organic Anion Transporting Polypeptide 2 (oatp2) by Prototypical Drug-Metabolizing Enzyme Inducers That Activate Gene Expression through Ligand-Activated Transcription Factor Pathways J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 206 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, H. Kusuhara, T. Sekine, H. Endou, and Y. Sugiyama Functional Characterization of Rat Organic Anion Transporter 2 in LLC-PK1 Cells J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1179 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Cha, T. Sekine, J.-i. Fukushima, Y. Kanai, Y. Kobayashi, T. Goya, and H. Endou Identification and Characterization of Human Organic Anion Transporter 3 Expressing Predominantly in the Kidney Mol. Pharmacol., April 16, 2001; 59(5): 1277 - 1286. [Abstract] [Full Text] |
||||
![]() |
D. Schwab, A. W. Herling, H. Hemmerle, G. Schubert, B. Hagenbuch, and H.-J. Burger Hepatic Uptake of Synthetic Chlorogenic Acid Derivatives by the Organic Anion Transport Proteins J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 91 - 98. [Abstract] [Full Text] |
||||
![]() |
H. C. Walters, A. L. Craddock, H. Fusegawa, M. C. Willingham, and P. A. Dawson Expression, transport properties, and chromosomal location of organic anion transporter subtype 3 Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1188 - G1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. Van Aubel, R. Masereeuw, and F. G. M. Russel Molecular pharmacology of renal organic anion transporters Am J Physiol Renal Physiol, August 1, 2000; 279(2): F216 - F232. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gao, B. Hagenbuch, G. A. Kullak-Ublick, D. Benke, A. Aguzzi, and P. J. Meier Organic Anion-Transporting Polypeptides Mediate Transport of Opioid Peptides across Blood-Brain Barrier J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 73 - 79. [Abstract] [Full Text] |
||||
![]() |
R. Raftogianis, C. Creveling, R. Weinshilboum, and J. Weisz Chapter 6: Estrogen Metabolism by Conjugation J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 113 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Konig, Y. Cui, A. T. Nies, and D. Keppler A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane Am J Physiol Gastrointest Liver Physiol, January 1, 2000; 278(1): G156 - G164. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gao, B. Stieger, B. Noé, J.-M. Fritschy, and P. J. Meier Localization of the Organic Anion Transporting Polypeptide 2 (Oatp2) in Capillary Endothelium and Choroid Plexus Epithelium of Rat Brain J. Histochem. Cytochem., October 1, 1999; 47(10): 1255 - 1264. [Abstract] [Full Text] |
||||
![]() |
J. Konig, Y. Cui, A. T. Nies, and D. Keppler Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide J. Biol. Chem., July 21, 2000; 275(30): 23161 - 23168. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Battaglia and J. Gollan A Unique Multifunctional Transporter Translocates Estradiol-17beta -Glucuronide in Rat Liver Microsomal Vesicles J. Biol. Chem., June 22, 2001; 276(26): 23492 - 23498. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |